ArticleCancers2022
Dramatic In Vivo Efficacy of the EZH2-Inhibitor Tazemetostat in
Thibault Passeri et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this papercites it
ArticleCancers2022
Thibault Passeri et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.